Abbott Admits Rival's Glucose Monitors May Not Infringe IP
Abbott has admitted in a London court that a Chinese rival's competing glucose monitor may not infringe its patents, yielding ground to its opponent in a lengthy dispute over their tech...To view the full article, register now.
Already a subscriber? Click here to view full article